Incidence of second primary cancers among survivors of childhood cancer: A population‐based study, Osaka, Japan, 1975

Incidence of second primary cancers among survivors of childhood cancer: A population‐based study, Osaka, Japan, 1975–2015

Published:2022-11-23 Issue:3 Volume:114 Page:1142-1153
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Science

Author:

Odani Satomi¹²^ORCID,Nakata Kayo¹^ORCID,Inoue Masami³,Kato Mizuki¹,Saito Mari Kajiwara¹,Morishima Toshitaka¹^ORCID,Hashii Yoshiko⁴,Hara Junich⁵^ORCID,Kawa Keisei³,Miyashiro Isao¹²

Affiliation:

1. Cancer Control Center Osaka International Cancer Institute Osaka Japan

2. Graduate School of Medicine Osaka University Osaka Japan

3. Department of Hematology/Oncology Osaka Women's and Children's Hospital Osaka Japan

4. Department of Pediatrics Osaka International Cancer Institute Osaka Japan

5. Department of Pediatric Hematology and Oncology Osaka City General Hospital Osaka Japan

Funder

Japan Society for the Promotion of Science

Ministry of Health, Labour and Welfare

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.15640

Reference53 articles.

1. Childhood cancer incidence and survival in Japan and England: A population-based study (1993-2010)

2. Trends in survival of leukemia among children, adolescents, and young adults: A population‐based study in Osaka, Japan

3. Cancer in adolescents and young adults in Japan: epidemiology and cancer strategy

4. Advances in paediatric cancer treatment;Saletta F;Translational Pediatrics,2014

5. Surveillance of Childhood Cancer Survivors: A Lifelong Affair

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence of survivors of childhood cancer based on a population‐based cancer registry in Osaka, Japan;International Journal of Cancer;2024-04-12

2. VersKiK: Study protocol of an observational registry-based study on the current state of follow-up care and adherence to follow-up guidelines after cancer in childhood or adolescence;Cancer Epidemiology;2023-12